Cannabis and Driving in Italy: Blood Tests Taken Hours Later Miss the Full Picture
In over 300 Italian DUI cases, delayed blood collection meant nearly half of cannabis-positive drivers tested positive only for inactive metabolites — making it impossible to confirm recent use or impairment.
Quick Facts
What This Study Found
When a driver is stopped for suspected impaired driving, the time between the traffic stop and the blood draw matters enormously for cannabis detection. THC is metabolized quickly, and delays of even a few hours can mean the difference between detecting active THC (indicating recent use) and only finding inactive metabolites (which can linger for days).
This five-year Italian study examined 318 cannabis-related DUI cases and found a fundamental problem with the system. Of all cannabis-positive drivers, only 143 (45%) tested positive for active THC. The remaining 173 (55%) tested positive only for the inactive metabolite THC-COOH — meaning their blood showed evidence of past cannabis use, but not necessarily recent use or current impairment.
The culprit was delayed sample collection. Italian forensic procedures often result in blood draws hours after the initial traffic stop, by which time active THC has been metabolized. In the THC-positive group, average concentrations were 4.05 ng/mL for THC and 28.29 ng/mL for the inactive metabolite. But for the majority who only had metabolites, there was no way to determine when they actually used cannabis or whether they were impaired at the time of driving.
This creates a legal and scientific problem: DUI cases built on metabolite-only results are scientifically weaker because they cannot distinguish a driver who smoked an hour ago from one who smoked three days ago.
Key Numbers
318 total DUI cases over 5 years (2017–2021). 143 (45%) positive for active THC + metabolites. 173 (55%) positive for inactive THC-COOH only. THC-positive group: mean THC 4.05 ng/mL, mean THC-COOH 28.29 ng/mL. The study highlights that delayed blood collection systematically reduces the ability to detect active THC.
How They Did This
Retrospective observational study of anonymized toxicological data from cannabis-related DUI cases (January 2017–December 2021) at the Legal Medicine and Toxicology Department, University Hospital of Padova, Italy. The 318 cases included drivers involved in road traffic accidents or apprehended by police. Blood samples were analyzed for THC, 11-OH-THC (active metabolite), and THC-COOH (inactive metabolite).
Why This Research Matters
This study quantifies a critical weakness in cannabis DUI enforcement: the testing timeline. Unlike alcohol, where breathalyzers give immediate results, cannabis requires blood draws that are often delayed by logistics (transport to hospital, waiting for medical staff). By the time blood is collected, the evidence of active impairment may have literally metabolized away. This has implications for both justice (prosecuting genuinely impaired drivers) and rights (protecting drivers who used cannabis days before driving).
The Bigger Picture
This connects directly to the workplace testing challenges documented in RTHC-00082 (workplace cannabis policies) and RTHC-00079 (oral fluid testing as a faster alternative). It also pairs with RTHC-00093 (driving ability after cannabis) and the standard THC unit work in RTHC-00089. Together, these studies highlight a systemic problem: our testing technology and procedures were designed for alcohol, and cannabis doesn't play by the same rules.
What This Study Doesn't Tell Us
Retrospective design using archived laboratory data — clinical details like the exact time of cannabis use, driving behavior observations, and field sobriety test results were not available. The study couldn't determine the actual delay between traffic stop and blood draw for each case. Italian forensic procedures may differ from other countries. The 5 ng/mL THC threshold used in many jurisdictions is itself debated in the literature.
Questions This Raises
- ?Should roadside oral fluid testing replace blood testing for cannabis DUI to reduce the delay problem?
- ?Would per se THC limits (like blood alcohol limits) be meaningful given how quickly THC is metabolized?
- ?How should courts treat cases where only inactive metabolites are found — is that sufficient evidence of impaired driving?
Trust & Context
- Key Stat:
- Evidence Grade:
- This is a retrospective analysis of forensic laboratory data. It clearly demonstrates the problem of delayed blood collection but cannot determine whether drivers were actually impaired. The five-year dataset from a university hospital provides a substantial sample.
- Study Age:
- Published in 2023, covering DUI cases from 2017–2021. The delay problem persists wherever blood draws are the primary cannabis testing method.
- Original Title:
- Driving under the influence of cannabis: A 5-year retrospective Italian study.
- Published In:
- Forensic science international, 353, 111854 (2023) — Forensic Science International is a reputable journal focusing on forensic science research.
- Authors:
- Favretto, Donata(3), Visentin, Cindi, Aprile, Anna, Terranova, Claudio, Cinquetti, Alessandro
- Database ID:
- RTHC-04538
Evidence Hierarchy
Looks back at existing records to find patterns.
What do these levels mean? →Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-04538APA
Favretto, Donata; Visentin, Cindi; Aprile, Anna; Terranova, Claudio; Cinquetti, Alessandro. (2023). Driving under the influence of cannabis: A 5-year retrospective Italian study.. Forensic science international, 353, 111854. https://doi.org/10.1016/j.forsciint.2023.111854
MLA
Favretto, Donata, et al. "Driving under the influence of cannabis: A 5-year retrospective Italian study.." Forensic science international, 2023. https://doi.org/10.1016/j.forsciint.2023.111854
RethinkTHC
RethinkTHC Research Database. "Driving under the influence of cannabis: A 5-year retrospect..." RTHC-04538. Retrieved from https://rethinkthc.com/research/favretto-2023-driving-under-the-influence
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.